Connect with us

Australia Startups

Australia-Based HealthTech Platform Clean Slate Raises $2.8M to Expand At-Home Addiction Recovery Into the UK

Clean Slate Clinic secures new funding to broaden UK’s addiction recovery access.

Published

on

Clean Slate Clinic, an innovative online platform focused on aiding individuals in their recovery from alcohol and drug addiction, has successfully secured AUD $4.3 million (US$2.8 million) in its latest funding round.

With this investment, the company plans to extend its services into the United Kingdom and enhance its digital offerings, thereby reaching more people seeking recovery solutions.

Founded in 2020 by Pia Clinton-Tarestad, Clean Slate Clinic offers an accessible, doctor-led treatment model that allows individuals to receive help within the privacy and comfort of their homes.

Co-founder Dr. Chris Davis emphasized the urgent need for such services, highlighting the alarming number of Australians consuming alcohol at harmful levels. Despite the prevalence of alcohol-related issues, safe and convenient detox options remain sparse, a gap that Clean Slate aims to fill with its online service.

Dr. Chris Davis pointed out that stigma and outdated treatment methods often discourage people from seeking the help they need. Specifically, professionals such as healthcare workers face challenges due to the fear of being recognized at traditional clinics. Clean Slate’s online model addresses this concern by offering confidential and easily accessible care directly to the home environment.

“Alcohol is the most common drug presentation in the Australian health system, yet safe, clinician-led detox at home has been virtually non-existent,” Dr. Davis explained. “Clean Slate changes that by giving people access to medical care at home when they are ready to seek help.” This home-based care model is also backed by many private health insurers in Australia, a testament to the clinic’s efficacy and acceptance.

Over 3,000 individuals have already benefited from Clean Slate’s services, detoxifying safely from substances including alcohol, stimulants, and cannabis.

Get Featured

The financial backing allows Clean Slate not only to enter the UK market but also to improve its digital services, ensuring a seamless experience for users in need of convenient healthcare solutions.

Given that only one in four people with alcohol dependence seeks treatment, and often after decades, the availability of Clean Slate’s services marks a significant advancement in accessible healthcare. As the company continues to expand and grow, it demonstrates a promising future for the field of telemedicine, particularly in the area of addiction recovery.

Subscribe to the Arab Founders Newsletter

The best entrepreneurship & investment stories from the Arab world — weekly, straight to your inbox

No ads. No fluff. No spam — we value your time.

Australia Startups

Australian AdTech Company Vudoo Raises $22M Series B Led by Blue Sky Capital to Expand Shoppable Advertising in the US

The investment will support the company’s expansion in the United States and further development of its interactive advertising and in-ad commerce technology.

Published

on

Australian AdTech company Vudoo has raised $22 million in a Series B funding round led by US-based investment firm Blue Sky Capital, with participation from several existing family office investors. The Melbourne-based company plans to use the capital to accelerate its expansion in the United States and strengthen its technology for enabling purchases directly within digital advertisements and video content.

Founded in 2017 by Nick Morgan and Andrew Spalding, Vudoo develops interactive advertising solutions that allow consumers to discover, explore and purchase products without leaving the digital content they are viewing. Its technology connects advertising engagement with e-commerce transactions, enabling brands to incorporate shopping functionality into digital media experiences.

The funding comes as Vudoo expands its presence in the US advertising market, strengthens its leadership team and develops its programmatic advertising capabilities. The company has also integrated its technology with advertising platform PubMatic, extending its potential reach across display, video and connected television (CTV) advertising inventory.

Get Featured

Vudoo Secures $22M Series B Funding Led by Blue Sky Capital

Vudoo’s $22 million Series B round was led by Blue Sky Capital, a US-based investment firm, with additional participation from existing family office investors. The financing will support the company’s international expansion strategy, with a particular focus on strengthening its commercial operations and technology capabilities in the United States.

The company plans to invest in its in-ad commerce platform, which enables advertisers to incorporate purchasing functionality directly into digital advertising formats. This approach is designed to reduce the number of steps between product discovery and purchase by allowing consumers to complete transactions within the advertising experience.

The latest funding will also support Vudoo’s efforts to expand its relationships with advertisers, publishers and advertising technology partners as it develops its presence in the US market.

The company has not disclosed its valuation following the Series B round, its cumulative funding to date or the individual contributions made by participating investors.

Vudoo Develops Shoppable Video and In-Ad Commerce Technology

Vudoo provides interactive advertising technology that allows consumers to engage with products and make purchases directly through video content and digital advertisements. Its platform is designed to connect advertising, product discovery and e-commerce within a single user experience.

Traditional digital advertising often directs consumers away from the content they are viewing to an external website or online store. Vudoo’s technology aims to simplify this process by embedding shopping functionality into the advertising environment itself.

For brands, the approach creates opportunities to connect consumer engagement with purchasing activity while reducing friction in the shopping journey. For publishers and advertisers, interactive commerce formats provide an additional way to incorporate transactional capabilities into digital content.

Vudoo’s technology supports the broader development of shoppable media, where advertising content serves not only as a promotional channel but also as a potential point of purchase.

The company has not disclosed the total transaction value processed through its platform, its number of active advertising customers or its current revenue.

Vudoo’s Vogue Australia Campaign Demonstrated In-Video Checkout

One of Vudoo’s earlier commercial campaigns was launched in 2022 in partnership with Vogue Australia for luxury brand Moët & Chandon. The campaign incorporated an in-video checkout feature that enabled consumers to purchase products directly through the content.

According to the reported campaign results, customers who used the shopping offer spent an average of $140, compared with typical online spending of $90. The figures indicated higher average spending among customers who engaged with the interactive shopping experience.

However, the comparison does not establish that the in-video checkout feature independently caused the difference in spending. The announcement did not disclose the campaign’s sample size, conversion rate or methodology used to calculate the spending figures.

The campaign provided an early example of Vudoo’s approach to integrating commerce functionality into branded digital content. Since then, the company has continued developing technology intended to make advertising formats more interactive and transaction-focused.

Vudoo Targets US Expansion as AI Reshapes Digital Commerce

Vudoo plans to use its Series B funding to expand its operations in the United States, where it is targeting opportunities in digital advertising, programmatic media and commerce-enabled content.

Nick Morgan, CEO and Co-founder of Vudoo, said consumer shopping behaviour is evolving as product discovery increasingly takes place through digital content and artificial intelligence environments.

“Commerce is moving beyond traditional storefronts, with the transaction moment shifting into the media, content and AI environments where consumers discover and engage with products,” Morgan said.

He explained that Vudoo has developed its technology to support this changing relationship between advertising, content and purchasing.

The company’s expansion strategy reflects its focus on enabling transactions closer to the point of product discovery, rather than requiring consumers to move through separate advertising and e-commerce environments.

Although Vudoo has identified AI-driven commerce as an opportunity, the announcement did not disclose a specific AI shopping product, integration with an AI assistant or a commercial launch timetable for new AI-related capabilities.

Vudoo Appoints New Executives to Support Global Growth

Alongside its funding announcement, Vudoo has strengthened its leadership team to support international expansion and commercial development.

The company promoted Isabella Spragg to Chief Operating Officer, placing her in charge of global operations. Spragg recently joined Vudoo as Global Director of Ad Infrastructure and Partnerships and previously held senior positions at The Trade Desk and Monks.

Her appointment is intended to support the company’s operational development as it expands across international advertising markets and strengthens its technology partnerships.

Vudoo has also appointed Tash Henderson as Managing Director to lead commercial operations in New York. Henderson previously worked at News Corp Australia and iHeartMedia’s Unified, bringing experience in media and advertising operations.

The leadership changes accompany Vudoo’s efforts to establish a stronger commercial presence in the United States while coordinating its global technology and partnership activities.

Vudoo Expands Programmatic Advertising Reach Through PubMatic Integration

In March 2026, Vudoo integrated its technology with PubMatic, an advertising technology platform, to expand the distribution of its shoppable advertising formats through programmatic advertising channels.

The integration provides access to advertising opportunities across display, video and connected television inventory. It is intended to help Vudoo extend its interactive commerce capabilities across different digital media environments.

Programmatic advertising uses technology to automate aspects of digital advertising transactions and delivery. By integrating with established advertising infrastructure, Vudoo aims to make its commerce-enabled formats accessible through a broader range of media placements.

The PubMatic integration supports Vudoo’s strategy of connecting advertising distribution with transactional functionality, allowing brands to explore shopping experiences across multiple digital channels.

The announcement did not disclose the commercial terms of the partnership, the number of campaigns delivered through the integration or the revenue generated from programmatic advertising.

Vudoo Competes With Meta and YouTube in Shoppable Advertising

Vudoo operates in a competitive digital commerce and advertising market where major technology platforms are increasingly incorporating shopping capabilities into content and advertising experiences.

Companies such as Meta and YouTube have developed commerce-related features that allow brands and creators to connect product discovery with purchasing opportunities. These developments reflect growing interest in reducing the distance between advertising engagement and consumer transactions.

Vudoo’s approach focuses on providing in-ad commerce technology that can be integrated into different advertising environments rather than operating solely within a single consumer-facing social media platform.

Its ability to expand will depend on attracting advertisers and publishers, maintaining compatibility with advertising infrastructure and demonstrating that interactive shopping formats deliver commercial value.

The company’s planned US expansion and its integration with PubMatic form part of its strategy to increase the availability of its technology across digital media channels.

Vudoo Raises $22M to Accelerate International Expansion

Vudoo’s $22 million Series B funding round marks a new stage in the Australian AdTech company’s expansion as it develops interactive advertising and in-ad commerce technology for international markets.

Led by Blue Sky Capital, with participation from existing family office investors, the financing will support Vudoo’s growth in the United States, strengthen its technology platform and expand its commercial operations.

Founded in Melbourne in 2017 by Nick Morgan and Andrew Spalding, Vudoo enables consumers to interact with and purchase products directly through digital advertisements and video content. Its technology aims to connect product discovery and transactions within the same media environment.

The company is building on its March 2026 integration with PubMatic and has appointed Isabella Spragg as Chief Operating Officer and Tash Henderson as Managing Director in New York to support its expansion plans.

With the new investment, Vudoo aims to strengthen its position in the shoppable advertising market as brands, publishers and advertising platforms explore new ways to integrate commerce into digital content.

Subscribe to the Arab Founders Newsletter

The best entrepreneurship & investment stories from the Arab world — weekly, straight to your inbox

No ads. No fluff. No spam — we value your time.

Continue Reading

Australia Startups

Airwallex Awards $1M in Equity-Free Funding to 10 Australian AI Startups Through Latitude 37 Programme to Support Global Expansion

The inaugural cohort will receive $100,000 per startup, alongside international networking opportunities and access to Airwallex’s investor and customer ecosystem.

Published

on

Airwallex, a global financial technology company founded in Australia, has announced the first cohort of its Latitude 37 programme, awarding a combined $1 million in equity-free funding to 10 Australian artificial intelligence startups.

Each selected company will receive $100,000 in non-dilutive funding, allowing founders to access capital without giving up ownership in their businesses. The programme will also provide participants with access to Airwallex’s network of investors, customers and industry partners, alongside international immersion trips to Singapore and San Francisco.

The inaugural cohort includes startups developing AI-powered solutions across robotics, education, financial services, aerospace, road safety and sports technology, reflecting the programme’s focus on supporting Australian technology companies with international growth potential.

Get Featured

Airwallex Launches $1M Latitude 37 AI Startup Programme

Latitude 37 is designed to support early-stage Australian startups developing artificial intelligence technologies with international growth potential. The programme combines direct financial support with access to industry expertise and international business networks, helping participating companies strengthen their products and explore opportunities beyond the Australian market.

Each of the 10 selected startups will receive $100,000 in equity-free funding to support product development and business expansion. Unlike traditional venture capital investments, the funding does not require founders to surrender an equity stake in their companies, allowing them to retain ownership while accessing additional financial resources.

Participants will also have opportunities to engage with potential customers, investors and technology industry leaders through Airwallex’s international network. The programme includes immersion trips to Singapore and San Francisco, providing founders with exposure to two major global technology ecosystems and opportunities to develop international business relationships.

Airwallex Co-Founder and CEO Jack Zhang said the initiative aims to make it easier for Australian entrepreneurs to build globally competitive companies without needing to relocate their businesses. Co-Founder Lucy Liu also highlighted the programme’s focus on building a community of founders with international ambitions, encouraging collaboration and connections across global markets.

Ten Australian AI Startups Selected for Inaugural Cohort

The first Latitude 37 cohort includes 10 startups developing artificial intelligence applications across different industries, ranging from consumer services and financial technology to robotics and industrial software.

The selected companies are:

  1. Polarbear AI: A Melbourne-based EdTech startup developing AI-powered tools that help students prepare for examinations and receive feedback on written assignments. Its technology focuses on supporting learning and assessment through automated educational assistance.
  2. SeatFinder: A travel technology platform that aggregates airline seat availability to help travelers identify premium seating opportunities at more affordable prices. The company aims to simplify the process of finding suitable travel options by organizing information about available airline seats.
  3. Superstat: A sports technology startup using computer vision to transform game footage into performance analytics, statistics and video highlights. Its platform is designed to extract structured performance information from sports videos and support data-driven analysis.
  4. SyncPay: A FinTech startup developing payment infrastructure that connects detailed transaction records with individual payments to simplify accounting and reconciliation. The technology aims to help businesses organize financial information and improve the management of payment-related records.
  5. Blank Robotics: A robotics company developing modular robotic systems for grocery retail operations. Its technology focuses on adaptable robotic solutions that can support different automation requirements within retail environments.
  6. Geospan: An AI-powered road intelligence startup developing technology to identify traffic obstacles and improve road safety. The company uses data analysis to support systems designed to detect potential hazards and provide information about road conditions.
  7. AXIOMS: A technology startup building interconnected networks of AI agents. Its platform focuses on enabling automated software agents to work together and coordinate tasks across connected systems.
  8. Forward: A financial technology company using artificial intelligence to structure private credit transactions. Its technology aims to support financial institutions in organizing and managing processes associated with private credit deals.
  9. Kronus: A software startup developing safety-critical technology for aerospace applications. The company focuses on software systems that require high levels of reliability and operational performance.
  10. Dreamscale Labs: A technology company building cloud infrastructure designed to support robotics development and deployment. Its platform aims to provide technical capabilities that help developers build, operate and scale robotic systems.

The cohort reflects the growing application of artificial intelligence across consumer services, enterprise software and industrial systems, with participating companies addressing different technical and operational challenges.

Supporting AI Innovation Across Multiple Industries

The selected startups represent a range of technologies, from AI-powered education platforms to advanced robotics and aerospace software. In education, Polarbear AI is developing tools that support examination preparation and provide automated feedback on student writing, while SeatFinder is applying technology to airline seat availability to help travelers identify premium travel options.

Superstat focuses on sports analytics, using computer vision to process video footage and generate performance data, statistics and highlights. The company recently secured $3.5 million in funding, demonstrating that the programme includes startups with existing investor backing as well as companies seeking additional support for their development.

In financial services, SyncPay is developing infrastructure to connect payments with transaction-level information, while Forward is applying AI to private credit structuring. Both companies are targeting financial workflows that can involve significant manual processing and fragmented information, with the aim of improving how financial data and transactions are organized.

The diversity of these applications reflects Latitude 37’s focus on supporting companies developing artificial intelligence technologies for different markets, rather than concentrating exclusively on a single industry or business model.

Robotics and Industrial AI Startups Join Latitude 37

Several companies in the inaugural cohort are developing technologies for physical-world applications, including robotics, transportation and aerospace. Blank Robotics is building modular robotic systems intended for grocery retail environments, while Geospan is developing road intelligence technology that uses AI to identify traffic obstacles and support safer transportation.

Dreamscale Labs is focused on cloud infrastructure for robotics, providing technology intended to support the development and operation of robotic systems. Its approach centers on creating software infrastructure that can help robotics developers manage and expand their applications.

Kronus is developing safety-critical software for aerospace applications, where reliability and system performance are essential. Meanwhile, AXIOMS is building networks of AI agents designed to support coordinated automated processes, focusing on the integration of intelligent software systems.

The inclusion of these startups reflects Latitude 37’s focus on technically complex products alongside consumer-facing AI applications, supporting companies working on technologies that require specialized engineering and infrastructure.

Airwallex Founders Focus on Global Startup Growth

Airwallex’s leadership has positioned Latitude 37 as an initiative intended to strengthen Australia’s technology startup ecosystem. Founded in Melbourne, Airwallex has expanded internationally, developing financial infrastructure for businesses operating across multiple markets, and is drawing on that experience to help emerging Australian startups access international networks and commercial opportunities.

Jack Zhang highlighted the ambition of the selected founders, particularly their focus on developing technically challenging AI products. Lucy Liu emphasized the importance of creating a founder community that encourages international thinking and collaboration, with the programme designed to connect entrepreneurs working across different technology sectors.

Latitude 37 aims to provide startups with opportunities to build relationships beyond Australia while continuing to develop their businesses locally. Its international immersion component is intended to expose participants to investors, customers and technology companies in Singapore and San Francisco, helping founders better understand the opportunities and requirements associated with global expansion.

Through these activities, Airwallex seeks to combine its international business experience with direct support for Australian startups, providing access to resources and relationships that may help participating companies pursue commercial growth.

Strengthening Australia’s AI Startup Ecosystem

The launch of Latitude 37 comes as Australian technology companies seek opportunities to compete in international artificial intelligence markets. Early-stage startups often require capital, technical resources and access to customers before they can establish a sustainable commercial presence, particularly when developing products intended for adoption across multiple markets.

Airwallex’s programme aims to address some of these challenges by combining non-dilutive funding with international business development opportunities. The initiative also provides a platform for founders working in different industries to exchange knowledge and build professional relationships, supporting collaboration among companies developing a range of AI technologies.

By selecting companies across financial services, robotics, education and industrial technology, Airwallex is supporting a broad range of AI applications. The first cohort will use the programme’s financial support and international networks to advance product development, strengthen commercial relationships and explore growth opportunities beyond Australia.

With $1 million in equity-free funding distributed across 10 startups, Latitude 37 represents Airwallex’s effort to support Australian founders developing AI technologies for global markets, while helping participating companies build international connections without relocating their operations.

Subscribe to the Arab Founders Newsletter

The best entrepreneurship & investment stories from the Arab world — weekly, straight to your inbox

No ads. No fluff. No spam — we value your time.

Continue Reading

Australia Startups

Australian Biotech Company Kinoxis Therapeutics Secures $9.25M in Funding and Grants to Advance Dementia and Pain Treatments

The new capital comprises an A$6.75 million financing round and a separate A$2.5 million government-backed research grant.

Published

on

Australian clinical-stage biotechnology company Kinoxis Therapeutics has secured A$9.25 million in new capital to advance experimental treatments for dementia-related agitation and pain.

The total includes an A$6.75 million financing round, featuring an A$5 million investment from new investor Main Sequence, alongside continued backing from existing shareholders. Kinoxis has separately received an A$2.5 million CUREator+ Dementia & Cognitive Decline grant funded by the Australian Government’s Medical Research Future Fund.

The company will use the financing to advance its portfolio of ALOX15 inhibitors, while the non-dilutive grant will specifically support the development of KNX101, its longer-acting drug candidate for chronic agitation and aggression associated with dementia.

Get Featured

Main Sequence Joins Kinoxis as New Investor

Main Sequence contributed A$5 million of the A$6.75 million financing and has joined Kinoxis as a new shareholder. The remaining capital came from existing investors, although the company did not identify the individual participants in the latest announcement.

Kinoxis’ existing shareholders include Uniseed, UniSuper, the University of Sydney, Stoic VC and Avicella Capital. The company previously raised A$14.5 million in a Series B round announced in 2024.

As part of the latest investment, Main Sequence healthcare investor Dr Elaine Stead will join the Kinoxis board. Stead has experience across healthcare investment, biotechnology commercialisation and corporate governance.

The investment gives Kinoxis additional resources to continue its clinical-stage programme while developing longer-acting compounds for potential use in dementia and pain treatment.

Targeting ALOX15 in Neurological Conditions

Founded in 2017 as a spinout from the University of Sydney, Kinoxis develops brain-penetrant small-molecule inhibitors targeting ALOX15.

ALOX15 is an intracellular enzyme that Kinoxis believes contributes to neural-circuit disruption, neuroinflammation and neurodegeneration. The company is investigating whether blocking the enzyme can reduce symptoms associated with dementia-related agitation and pain.

Kinoxis was founded by Professor Michael Kassiou, Professor Michael Bowen and biotechnology executive Hugh Alsop. Bowen serves as chief scientific officer, while Alsop leads the company as chief executive.

The company’s technology remains under clinical and preclinical evaluation, meaning its drug candidates have not yet been approved for commercial use. Their safety and effectiveness must still be demonstrated through clinical trials and regulatory review.

KNX100 Advances Through Phase 2 Trial

Kinoxis’ lead candidate, KNX100, is a rapid, short-acting ALOX15 inhibitor being evaluated in the CARES-X Phase 2 trial in Australia.

The multicentre, randomised and placebo-controlled study is assessing the safety, tolerability and potential effectiveness of KNX100 in people experiencing agitation associated with dementia.

Kinoxis said the trial has passed 50% of its recruitment target and is expected to report topline results in mid-2027. Recruitment has expanded from community-based participants into hospital dementia wards and residential aged-care facilities, giving the study access to people with more advanced dementia and potentially more frequent or severe agitation.

The company is developing KNX100 as a targeted treatment for persistent agitation and as a rapid intervention for acute agitation episodes.

Government Grant Supports KNX101 Development

The A$2.5 million CUREator+ grant will support KNX101, a next-generation, longer-acting ALOX15 inhibitor.

Kinoxis is developing the candidate for chronic agitation and aggression associated with dementia, as well as acute and chronic pain. The company expects to begin the toxicology studies required to support a future Investigational New Drug application by the end of 2026.

CUREator+ provides non-dilutive funding to commercially oriented Australian medical research projects. Funding is released in tranches linked to predetermined development milestones.

The programme is funded through the Australian Government’s Medical Research Future Fund and delivered by Brandon BioCatalyst in partnership with ANDHealth and Dementia Australia. Projects can receive as much as A$5 million across two competitive funding stages.

Preparing for Clinical Data and Partnerships

Kinoxis will now focus on completing recruitment for the CARES-X study, preparing KNX101 for further preclinical testing and advancing additional long-acting ALOX15 inhibitors.

The company is also exploring potential applications in alcohol use disorder, although dementia-related agitation and pain remain the primary areas of development.

With the new financing and grant support, Kinoxis plans to pursue strategic partnerships across neuropsychiatry and pain while preparing for KNX100’s Phase 2 results in 2027. Its progress will ultimately depend on whether its drug candidates can demonstrate acceptable safety and meaningful clinical benefits in controlled studies.

Subscribe to the Arab Founders Newsletter

The best entrepreneurship & investment stories from the Arab world — weekly, straight to your inbox

No ads. No fluff. No spam — we value your time.

Continue Reading

Most popular